Low-power active bone conduction devices

US9794703B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9794703-B2
Application numberUS-201414317410-A
CountryUS
Kind codeB2
Filing dateJun 27, 2014
Priority dateJun 27, 2014
Publication dateOct 17, 2017
Grant dateOct 17, 2017

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Presented herein are low-power active bone conduction devices that comprise an actuator that is subcutaneously implanted within a recipient so as to deliver mechanical output forces to hard tissue of the recipient. The low-power active bone conduction devices include an energy recovery circuit configured to extract non-used energy from the actuator and to store the non-used energy for subsequent use by the actuator. The low-power active bone conduction devices may also include a multi-bit sigma-delta converter that operates in accordance with a scaled sigma-delta quantization threshold value to convert received signals representative of sound into actuator drive signals.

First claim

Opening claim text (preview).

What is claimed is: 1. An ultra-low power active bone conduction device utilizing less than approximately two Milliwatts (mW) of power for operation, comprising: an actuator configured to be subcutaneously implanted within a recipient so as to deliver mechanical output forces to hard tissue of the recipient; a sigma-delta converter configured to convert received signals representative of sound into a serialized bit stream of sigma-delta pulses and to perform scaling of the sigma-delta pulses using a scaled sigma-delta quantization threshold level to limit a number of sigma-delta pulses in the serialized bit stream, wherein the sigma-delta converter performs the scaling only when a level of the received signals representative of sound is below an audio threshold level; and an audio driver configured to receive the serialized bit stream of sigma-delta pulses for use in driving the actuator; and an energy recovery circuit configured to extract non-used energy from the actuator and to store the non-used energy for subsequent use by the actuator. 2. The ultra-low power active bone conduction device of claim 1 , wherein the energy recovery circuit comprises: at least one energy recovery inductor connected in series between the audio driver and actuator; and an energy recovery tank circuit comprising a rechargeable power supply. 3. The ultra-low power active bone conduction device of claim 2 , wherein the rechargeable power supply is at least one of a capacitor and a rechargeable battery. 4. The ultra-low power active bone conduction device of claim 2 , wherein the at least one energy recovery inductor comprises first and second energy recovery inductors disposed on opposing sides of the actuator. 5. The ultra-low power active bone conduction device of claim 2 , wherein the actuator operates as a low-equivalent series resistance (ESR) capacitor having a capacitance of at least approximately 1 microfarad (μF) and an ESR less than approximately 10 ohms. 6. The ultra-low power active bone conduction device of claim 5 , wherein the rechargeable power supply of the energy recovery tank circuit has a charge capacity of at least 10 times higher than the charge capacity of the low-ESR capacitance of the actuator. 7. The ultra-low power active bone conduction device of claim 1 , further comprising: an external zinc-air battery configured to provide transcutaneous energy to the energy recovery circuit to compensate for the losses in the energy recovery circuit. 8. The ultra-low power active bone conduction device of claim 1 , wherein the audio threshold level below which the sigma-delta converter performs scaling of the sigma-delta pulses is configurable for the recipient. 9. The ultra-low power active bone conduction device of claim 1 , further comprising: an implantable coil configured to receive control data from an external device, wherein the control data comprises the scaled sigma-delta quantization threshold level, and wherein the sigma-delta converter includes an input at which the scaled sigma-delta quantization threshold level used by the sigma-delta converter is set to a selected level. 10. The ultra-low power active bone conduction device of claim 9 , wherein the scaled sigma-delta quantization threshold level is programmable at the external device and sent to the implantable coil. 11. The ultra-low power active bone conduction device of claim 1 , wherein the actuator is a piezoelectric actuator. 12. The ultra-low power active bone conduction device of claim 1 , wherein the active bone conduction device utilizes less than approximately two mW of average power. 13. The bone conduction device of claim 1 , wherein the actuator is a piezoelectric actuator. 14. The bone conduction device of claim 1 , wherein the bone conduction device is an active bone conductive device. 15. The bone conduction device of claim 14 , further comprising: an implantable coil configured to receive control data from an external device, wherein the control data comprises the scaled sigma-delta quantization threshold level, and wherein the sigma-delta converter includes an input at which the scaled sigma-delta quantization threshold level used by the sigma-delta converter is set to a selected level. 16. The bone conduction device of claim 15 , wherein the scaled sigma-delta quantization threshold level is programmable at the external device and sent to the implantable coil. 17. A bone conduction device, comprising: an audio driver having first and second sides; an implantable actuator comprising a capacitive element; a multi-bit sigma-delta converter configured to receive a set of audio signals and to convert the set of audio signals into first and second sets of sigma-delta signals for delivery to the first and second sides, respectively, of the audio driver, wherein the sigma-delta converter operates to scale the sigma-delta signals using a scaled sigma-delta quantization threshold to introduce distortion into the first and second sets of sigma-delta signals only when the set of audio signals has an amplitude that is below a predetermined threshold; wherein the audio driver is configured to deliver the first and second sets of sigma-delta signals to the actuator in a manner that charges and discharges the capacitive element; and an energy recovery circuit configured to extract energy from the capacitive element while the capacitive element discharges and to add energy to the capacitive element while the capacitive element charges. 18. The bone conduction device of claim 17 , wherein the energy recovery circuit comprises: at least one energy recovery inductor connected in series between the audio driver and actuator; and an energy recovery tank circuit comprising a rechargeable power supply. 19. The bone conduction device of claim 18 , wherein the rechargeable power supply comprises at least one of a capacitor and a rechargeable battery. 20. The bone conduction device of claim 18 , wherein the at least one energy recovery inductor comprises first and second energy recovery inductors disposed on opposing sides of the actuator. 21. The bone conduction device of claim 18 , wherein the rechargeable power supply of the energy recovery tank circuit has a charge capacity of at least 10 times higher than the charge capacity of the capacitive element of actuator. 22. The bone conduction device of claim 17 , wherein the multi-bit sigma-delta converter is a sixteen-bit audio converter and wherein the predetermined threshold level is configurable for the recipient. 23. The bone conduction device of claim 17 , further comprising: an implantable coil configured to receive control data from an external device, wherein the control data comprises the predetermined threshold level. 24. The bone conduction device of claim 17 , wherein the actuator comprises a piezoelectric actuator. 25. A bone conduction device, comprising: an actuator configured to deliver mechanical output forces to a recipient; a sigma-delta converter configured to convert received signals representative of sound into at least one serialized bit stream of sigma-delta pulses and to perform scaling of the sigma-delta pulses based on a scaled sigma-delta quantization threshold level to limit a number of sigma-delta pulses in the at least one serialized bit stream, wherein the sigma-delta converter performs the scaling only when a level of the received signals representative of sound

Assignees

Inventors

Classifications

  • Hearing devices using bone conduction transducers · CPC title

  • adapted to be supported entirely by ear · CPC title

  • H04R25/606Primary

    acting directly on the eardrum, the ossicles or the skull, e.g. mastoid, tooth, maxillary or mandibular bone, or mechanically stimulating the cochlea, e.g. at the oval window · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9794703B2 cover?
Presented herein are low-power active bone conduction devices that comprise an actuator that is subcutaneously implanted within a recipient so as to deliver mechanical output forces to hard tissue of the recipient. The low-power active bone conduction devices include an energy recovery circuit configured to extract non-used energy from the actuator and to store the non-used energy for subsequen…
Who is the assignee on this patent?
Cochlear Ltd
What technology area does this patent fall under?
Primary CPC classification H04R25/606. Mapped technology areas include Electricity.
When was this patent published?
Publication date Tue Oct 17 2017 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).